Non-specific code 2014 ICD-9-CM Diagnosis Code 207.2
Megakaryocytic leukemia
  • Non-Billable Code
  • There are 3 ICD-9-CM codes below 207.2 that define this diagnosis in greater detail. Do not use this code on a reimbursement claim.
Clinical Information
  • A progressive, proliferative disease of blood cells, originating from immature megakaryocytes.
  • An acute myeloid leukemia in which 20-30% of the bone marrow or peripheral blood cells are of megakaryocyte lineage. Myelofibrosis or increased bone marrow reticulin is common.
  • An acute myeloid leukemia in which at least 50% of the blasts are of megakaryocytic lineage. The prognosis is usually poor. (who, 2001)
Applies To
  • Megakaryocytic myelosis
  • Thrombocytic leukemia
ICD-9-CM Volume 2 Index entries containing back-references to 207.2:
  • Leukemia, leukemic (congenital) (M9800/3) 208.9
    • giant cell (M9910/3) 207.2
    • megakaryocytic (M9910/3) 207.2
    • megakaryocytoid (M9910/3) 207.2
    • thrombocytic (M9910/3) 207.2
  • Myelosis (M9860/3) (see also Leukemia, myeloid) 205.9
    • megakaryocytic (M9920/3) 207.2
ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions. ICD-9-CM 207.2 is one of thousands of ICD-9-CM codes used in healthcare. Although ICD-9-CM and CPT codes are largely numeric, they differ in that CPT codes describe medical procedures and services. Can't find a code? Start at the root of ICD-9-CM, check the 2014 ICD-9-CM Index or use the search engine at the top of this page to lookup any code.